We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+0.46%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$310M
AUM Growth
-$27.7M
Cap. Flow
-$24.8M
Cap. Flow %
-7.98%
Top 10 Hldgs %
9.28%
Holding
552
New
39
Increased
13
Reduced
171
Closed
90

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$1.78M
2
VZ icon
Verizon
VZ
+$1.71M
3
PFE icon
Pfizer
PFE
+$1.69M
4
ABBV icon
AbbVie
ABBV
+$1.66M
5
RTX icon
RTX Corp
RTX
+$1.6M

Top Sells

Rank Stock Value
1
APP icon
Applovin
APP
+$2.3M
2
MTB icon
M&T Bank
MTB
+$1.83M
3
MRO
Marathon Oil Corporation
MRO
+$1.57M
4
FANG icon
Diamondback Energy
FANG
+$1.25M
5
BKR icon
Baker Hughes
BKR
+$1.12M

Sector Composition

Rank Sector Weight
1 Financials 21.3%
2 Technology 16.45%
3 Healthcare 11.76%
4 Industrials 11.27%
5 Consumer Discretionary 8.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
526
Replimune Group
REPL
$1.15B
-12,167
Closed -$133K
REX icon
527
REX American Resources
REX
$1.43B
-9,098
Closed -$211K
REYN icon
528
Reynolds Consumer Products
REYN
$5.51B
-8,978
Closed -$279K
RLAY icon
529
Relay Therapeutics
RLAY
$4.37B
-10,811
Closed -$76.5K
SANA icon
530
Sana Biotechnology
SANA
$1B
-16,218
Closed -$67.5K
SONO icon
531
Sonos
SONO
$1.83B
-43,836
Closed -$539K
STRO icon
532
Sutro Biopharma
STRO
$423M
-1,856
Closed -$64.2K
T icon
533
AT&T
T
$165B
-38,837
Closed -$854K
TCRX icon
534
TScan Therapeutics
TCRX
$50.1M
-10,788
Closed -$53.7K
TEX icon
535
Terex
TEX
$7.58B
-4,274
Closed -$226K
TNYA icon
536
Tenaya Therapeutics
TNYA
$165M
-30,222
Closed -$58.3K
TRNO icon
537
Terreno Realty
TRNO
$7.45B
-7,893
Closed -$527K
UPWK icon
538
Upwork
UPWK
$1.21B
-16,334
Closed -$171K
URBN icon
539
Urban Outfitters
URBN
$6.81B
-6,508
Closed -$249K
VIR icon
540
Vir Biotechnology
VIR
$1.5B
-10,587
Closed -$79.3K
VNDA icon
541
Vanda Pharmaceuticals
VNDA
$304M
-16,101
Closed -$75.5K
VSTM icon
542
Verastem
VSTM
$615M
-11,810
Closed -$35.3K
VYGR icon
543
Voyager Therapeutics
VYGR
$195M
-10,937
Closed -$64K
WMG icon
544
Warner Music
WMG
$13.8B
-21,587
Closed -$676K
WS icon
545
Worthington Steel
WS
$1.94B
-7,672
Closed -$261K
ZION icon
546
Zions Bancorporation
ZION
$10.3B
-10,799
Closed -$510K
NPKI
547
NPK International
NPKI
$1.15B
-37,325
Closed -$259K
PSTX
548
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-43,177
Closed -$123K
MRO
549
DELISTED
Marathon Oil Corporation
MRO
-58,966
Closed -$1.57M
PETQ
550
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-26,441
Closed -$814K

Similar funds

Cornercap Investment Counsel's Q4 2024 Portfolio in Review

As of Q4 2024, Cornercap Investment Counsel held 552 positions worth $310M, down 8.2% from $338M the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Cornercap Investment Counsel withdrew a net $24.8M in Q4 2024, closing 90 positions and reducing 171 holdings. Its most notable exit was M&T Bank, an estimated $1.83M position sold in full.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cornercap Investment Counsel opened a new position in Charles Schwab worth $1.76M.

  • Cornercap Investment Counsel's largest Q4 2024 buy was Charles Schwab: 23,724 shares worth $1.76M.
  • Cornercap Investment Counsel added most to ConocoPhillips in Q4 2024, an estimated $1.47M increase.
  • Cornercap Investment Counsel's biggest Q4 2024 reduction was Applovin, cutting an estimated $2.3M.
  • Cornercap Investment Counsel fully exited M&T Bank in Q4 2024, selling an estimated $1.83M.
  • Cornercap Investment Counsel's ten largest holdings make up 9.3% of its $310M portfolio in Q4 2024.
  • Cornercap Investment Counsel opened 39 new positions and closed 90 in Q4 2024.
  • Cornercap Investment Counsel's portfolio value fell 8.2% quarter-over-quarter to $310M.

Based on Cornercap Investment Counsel's 13F filing for Q4 2024, filed 12 Feb 2025.